Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1831-1840 Newer>

The Motley Fool March 2, 2005 Stephen D. Simpson	CardioDynamics' Palpitations The small-cap medical device maker has a good device, but driving growth is a bit tougher. An investment in CardioDynamics will be an exercise in patience.
The Motley Fool March 2, 2005 Dave Marino-Nachison	Henry Schein Shines On Trouble with partner Chiron's full vaccines hasn't stopped Henry Schein's share rise.
The Motley Fool March 2, 2005 Rich Smith	ViaCell Under the Microscope Cord blood collector makes its first earnings announcement tomorrow. Investors will likely be shining harsh lights on the company's financial statements.
BusinessWeek March 7, 2005 Arlene Weintraub	Where VCs Fear To Tread Angel investors are filling a critical gap by providing early backing for biotechs.
The Motley Fool March 1, 2005 Stephen D. Simpson	When Bad News Is Good News The withdrawal of Tysabri is terrible news for Biogen Idec and Elan, but other firms may benefit.
The Motley Fool March 1, 2005 Charly Travers	From Rags to Riches One biotech's fate reveals the formula for spotting turnaround investments. BioMarin has yet to turn the corner, but that time is quickly approaching.
Managed Care February 2005 Martin Sipkoff	Power to the People: Newt's Battle Cry An interview with former speaker of the house Newt Gingrich, who strongly favors a free-market overhaul of the health care system that would change the way consumers behave. Should you worry?
Managed Care February 2005 Tony Berberabe	Information: It's Better When You Share Today's version of a community health information network, the regional health information organization, is a collaborative of health plans, health care providers, and hospitals in a given geographic area that collects patient information stored on a secure Web site.
Managed Care February 2005 Jack McCain	Managed Care (and Everyone Else) Unprepared for the Next Killer Flu Could avian flu give rise to a pandemic that might rival the fearsome Spanish flu? Is the nation ready? Health plans may be called upon to administer vaccinations and identify high-risk patients, but what about he millions of Americans who lack health insurance?
Managed Care February 2005 Mark Zitter	Managing Drugs for Rare Genetic Diseases: Trends and Insights Evaluates recent trends and challenges in health system management of exceedingly rare genetic diseases, from the perspective of the manufacturer, managed care organization, physician, and actuary.
<Older 1831-1840 Newer> Return to current articles.